$0.3872
0.02717.53%
Last update: Nov 12, 4:19 PM
Ensysce Biosciences Inc (ENSC) Stock Price, Quote, News & History
ENSCNASDAQ
Ensysce Biosciences stock surged 58% after launching a strategic review to explore partnerships, licensing deals, or asset sales.
You can purchase shares of Ensysce Biosciences (NASDAQ:ENSC) through any online brokerage.
Other companies in Ensysce Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Ensysce Biosciences has a consensus price target of $2.00.
The stock price for Ensysce Biosciences (NASDAQ: ENSC) is $0.3871 last updated November 12, 2026 at 4:19 PM EST.
There are no upcoming dividends for Ensysce Biosciences.
Ensysce Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Ensysce Biosciences.
Ensysce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its...
